Inventor · disambiguated record
Hiroyuki Kouji
Also filed as: KOUJI HIROYUKI
16 granted patents·20 pending applications·18 citations·filing 1985–2023
87Inventor score
Top patents by PatentIndex Score
36 records- 0185US8455488B2Alpha helix mimetics and methods relating theretoODAGAMI TAKENAO·Filed 2009·Granted Jun 4, 2013·12 cites·5 claims
- 0270US8691819B2Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditionsKOUJI HIROYUKI·Filed 2009·Granted Apr 8, 2014·2 cites·26 claims
- 0361US11780841B23,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-c]pyridine compounds and medicaments using sameIRIMAJIRI THERAPEUTICS INC·Filed 2022·Granted Oct 10, 2023·0 cites·14 claims
- 0459US12024571B2Anti-erythropoietin receptor peptideEPO MED INC·Filed 2019·Granted Jul 2, 2024·0 cites·1 claims
- 0557US2025304616A1Novel peptidomimetic compound and designIrimaiiri Therapeutics Inc·Filed 2021·Application pending·0 cites
- 0655US2023390296A1Novel treatment and prevention of sarcopenia-related diseasesUNIV KEIO·Filed 2021·Application pending·0 cites
- 0754US2025250282A1Novel seven-membered ring-fused compoundsPRISM BIOLAB CO LTD·Filed 2023·Application pending·0 cites
- 0853US9700569B2Prevention or treatment agent for hepatic fibrosisPRISM PHARMA CO LTD·Filed 2013·Granted Jul 11, 2017·0 cites·4 claims
- 0952US11292794B23,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using sameOITA UNIV INSTITUTE OF ADVANCED MEDICINE INC·Filed 2020·Granted Apr 5, 2022·0 cites·18 claims
- 1051US9126981B2Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditionsPRISM BIOLAB CORP·Filed 2014·Granted Sep 8, 2015·0 cites·1 claims
- 1151US2024309006A1Novel bicyclic compoundsPRISM BIOLAB CO LTD·Filed 2022·Application pending·0 cites
- 1249US10265331B2Prevention or treatment agent for hepatic fibrosisPRISM PHARMA CO LTD·Filed 2017·Granted Apr 23, 2019·0 cites·2 claims
- 1349US2018305373A1Alpha helix mimetics and methods relating theretoPRISM BIOLAB CO LTD·Filed 2018·Application pending·0 cites
- 1448US4964905AN-substituted-phenylteraconimide compound, herbicidal composition, and method for the destruction of undesirable weedsASAHI CHEMICAL IND·Filed 1986·Granted Oct 23, 1990·3 cites·25 claims
- 1548US2016166578A1Method for treating type i and type ii diabetesPRISM PHAMA LTD·Filed 2013·Application pending·0 cites
- 1647US2023310539A1Treatment of disease with epor antagonistEPO MED INC·Filed 2021·Application pending·0 cites
- 1745US9193734B2Alpha helix mimetics and methods relating theretoPRISM BIOLAB CORP·Filed 2013·Granted Nov 24, 2015·0 cites·15 claims
- 1845US9040531B2Alpha helix mimetics and methods relating theretoODAGAMI TAKENAO·Filed 2010·Granted May 26, 2015·0 cites·7 claims
- 1945US2023374034A1Novel bicyclic compoundsPRISM BIOLAB CO LTD·Filed 2021·Application pending·0 cites
- 2043US12310955B2Cyclic amide compounds for rabies treatment and method thereofIRIMAJIRI THERAPEUTICS INC·Filed 2020·Granted May 27, 2025·0 cites·32 claims
- 2143US11369623B2Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitorPRISM PHARMA CO LTD·Filed 2016·Granted Jun 28, 2022·0 cites·1 claims
- 2243US9682996B2Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditionsPRISM BIOLAB CO LTD·Filed 2015·Granted Jun 20, 2017·0 cites·27 claims
- 2342US10017522B2Alpha helix mimetics and methods relating theretoPRISM BIOLAB CO LTD·Filed 2015·Granted Jul 10, 2018·0 cites·17 claims
- 2442US2016318938A1CRYSTALS (2) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUNDPRISM PHARMA CO LTD·Filed 2014·Application pending·0 cites
- 2542US2016318957A1CRYSTAL (1) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUNDPRISM PHARMA CO LTD·Filed 2014·Application pending·0 cites
- 2641US2016215007A1Method of producing pyrazino[2,1-c][1,2,4]triazine compoundPRISM PHARMA CO LTD·Filed 2014·Application pending·0 cites
- 2741US2014275295A1Method for treating type i and type ii diabetesKOUJI HIROYUKI·Filed 2012·Application pending·0 cites
- 2838US2016166577A1Treatment of pulmonary fibrosis using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2938US2015283145A1Treatment of hyperproliferative and pre-cancerous skin diseases using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 3038US2015274751A1Treatment of scleroderma using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 3138US2016263131A1Treatment of hepatic fibrosis using an inhibitor of cbp/cateninKOUJI HIROYUKI·Filed 2014·Application pending·0 cites
- 3238US2015284393A1Methods for treating eye disordersPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 3337US2016244453A1Treatment of viral and infectious diseases using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 3436US4698094A2-nitro-5-(2'chloro-4'trifluoromethylphenoxy)-phenylacetic esters, herbicidal composition, and method for destruction of undesirable weedsASAHI CHEMICAL IND·Filed 1985·Granted Oct 6, 1987·1 cites·17 claims
- 3534US2012296067A1Compound capable of binding to naturally occurring denatured protein, and method for screening for the compoundKOUJI HIROYUKI·Filed 2011·Application pending·0 cites
- 3632US2014051706A1Alpha helix mimetics and methods relating theretoKOUJI HIROYUKI·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hiroyuki Kouji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →